The novel treatment of tirzepatide peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide402539.livebloggs.com/48807759/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment